Heritage Pharmaceuticals announced the launch of Prochlorperazine Edisylate Injection, the generic version of GlaxoSmithKline’s former brand Compazine.

RELATED: Gastrohepactic Disorders Resource Center

Prochlorperazine Edisylate is a piperazine phenothiazine indicated for the treatment of severe nausea and vomiting. Like other phenothiazines, it exerts an antiemetic effect through a depressant action on the chemoreceptor trigger zone. It also has a clinically useful antipsychotic effect.

Prochlorperazine Edisylate Injection is available as a 5mg/mL strength in 2mL vials in 10- and 25-count packages. The product is available immediately.

For more information call (866) 901-1230 or visit HeritagePharma.com